Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells

Despite comprehensive genomic analyses, no targeted therapies are approved for bladder cancer. Here, we investigate whether a single and combination therapy with targeted agents exert antitumor effects on bladder cancer cells through genomic alterations using a three-dimensional (3D) high-throughput...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyera, Lee, Su Jin, Lee, In Kyoung, Min, Suejean C., Sung, Hyun Hwan, Jeong, Byong Chang, Lee, Jeeyun, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215775/
https://www.ncbi.nlm.nih.gov/pubmed/32325639
http://dx.doi.org/10.3390/ijms21082825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215775/
https://www.ncbi.nlm.nih.gov/pubmed/32325639
http://dx.doi.org/10.3390/ijms21082825

Ejemplares similares